Abstract:Objective To investigate the role of new contrast agent (SonoVue) and real time gray-scale contrast tuned imaging (CnTI) in the evaluation of the perfusion and echogenicity of liver neoplasms and to discuss the diagnostic value and radiofrequency ablation application. Methods Thirty-five patients with unconfirmed liver neoplasms were enrolled in our study. Nine of them were diagnosed clinically, while the other 26 cases with pathological evidence through surgery or needle biopsy. Twenty-three were hepatocellular carcinoma (HCC), 5 were liver metastases, and 7 were benign diseases. Fourteen of the 28 malignant cases were examined before radiofrequency ablation(RFA) of the liver neoplasms. Results Among the 23 cases of typical HCC, 21 (91.3%) presented with early artery enhancement and immediate wash-out, while the other 2 cases of small (2 cm) hyper-differentiated HCC washed out slowly. The enhancement pattern of 5 liver metastastic cases was diverse, including peripheral or various degree enhancement in the arterial or portal phase with slow or fast wash-out. The 3 cases of haemangioma were enhanced centripetally in portal phase and washed out after several minutes without arterial enhancement and the other 4 benign cases without typical enhancement. Twenty-six lesions of 14 patients were observed with contrast ultrasound before RF ablation, 9 lesions (34.6%) of which showed feeding vessels, 12 lesions (46.1%) tended to be larger, especially those with unclear margins and without halo sign. This might help to recognize the ablation safe margin. Conclusion The new contrast ultrasound technique is sensitive and effective in diagnosing liver neoplasms. Recognizing the size and number of lesions and detecting minute foci greatly improved the value of contrast ultrasound in diagnosis of liver neoplasms. It will also help to choose the indicator and establish the protocol of local treatment methods.

The role of new contrast agent and contrast-enhanced gray-scale ultrasound in the diagnosis of liver neoplasms

The Clinical Use of Contrast - Enhanced Gray - Scale Ultrasonography in the Diagnosis of Focal Liver Lesions

The role of real-time contrast-enhanced ultrasonography in the diagnosis of liver metastasis

Hemodynamic analysis of real-time enhanced-ultrasonography in diagnosis of focal liver lesions

Comparison of enhancement features of hepatic tumors on SonoVue-enhanced real-time gray-scale ultrasonography and contrast-enhanced helical CT

Assessment of vascularity of hepatocellular carcinoma with real-time contrast-enhanced sonography

Comparison of enhancement features of hepatic tumors on contrast-enhanced ultrasonography and helical CT

Contrast-enhanced ultrasound in liver tumors

Evaluation of treatment response in hepatocellular carcinoma with contrast-enhanced harmonic sonography

Enhancement pattern of atypical liver haemangioma with contrast-enhanced ultrasound

Primarily diagnostic criteria of focal liver lesions using contrast enhanced ultrasound

Effects of post-contrast enhanced ultrasonography on characterization of focal liver lesions

Differential diagnosis between renal malignant and benign tumors with contrast-enhanced ultrasound

The value of contrast-enhanced harmonic ultrasound for hilar cholangiocarcinoma

Contrast-enhanced color Doppler ultrasonography of small hepatic lesions

New gray scale contrast ultrasound technique in liver neoplasms diagnosis and radiofrequency ablation application

Differentiation diagnosis of contrast enhancing inflammatory liver lesions and hepatocellular carcinoma with contrast enhanced ultrasound

Contrast-enhanced ultrasonography of renal cell carcinomas:compared to contrast-enhanced CT

Contrast-enhanced ultrasound in the characteristics of renal tumors

Clinical value of contrast-enhanced ultrasonography in diagnosis of testicular torsion

Comparative the Clinical Value of Contrast-Enhanced Ultrasonography, Enhancement CT and MRI for Diagnosing of Liver Lesions.